Impel Pharmaceuticals Inc.
IMPLNASDAQHealthcare
$0.04
$-0.02(-27.27%)
Market Cap$956000
P/E Ratio—
52W High$4.2
52W Low$0.0212
Impel Pharmaceuticals Inc.（IMPL）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IMPL · 截至 2026-06-09
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Assets | ||||
| Cash & ST Investments | $60.65M | $88.21M | $7.09M | $37.00M |
| Net Receivables | $7.44M | $1.35M | $0.00M | $0.00M |
| Inventory | $8.43M | $2.82M | $0.00M | $0.00M |
| Total Current Assets | $79.81M | $94.58M | $8.17M | $39.52M |
| PP&E Net | $7.00M | $3.15M | $3.70M | $2.74M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $88.55M | $97.91M | $12.06M | $42.27M |
| Liabilities | ||||
| Short-Term Debt | $1.54M | $0.00M | $0.42M | $0.00M |
| Accounts Payable | $6.09M | $6.37M | $4.31M | $2.73M |
| Total Current Liabilities | $22.16M | $15.95M | $10.53M | $8.32M |
| Long-Term Debt | $49.65M | $29.45M | $7.99M | $0.00M |
| Total Liabilities | $132.71M | $45.40M | $145.56M | $133.97M |
| Stockholders Equity | ||||
| Retained Earnings | ($321.11M) | ($214.80M) | ($138.26M) | ($92.46M) |
| Total Stockholders Equity | ($44.16M) | $52.51M | ($133.50M) | ($91.70M) |
| Total Liab & Equity(computed) | $88.55M | $97.91M | $12.06M | $42.27M |
| Debt Summary | ||||
| Total Debt | $51.19M | $29.45M | $8.41M | $0.00M |
| Net Debt | ($9.47M) | ($58.76M) | $1.32M | ($37.00M) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Impel Pharmaceuticals Inc.
关于Impel Pharmaceuticals Inc.（IMPL）资产负债表
Impel Pharmaceuticals Inc.总资产$0.09B，现金及短期投资$0.06B，总负债$0.13B，总债务$0.05B，股东权益($0.04B)。
常见问题
IMPL · 4 问Impel Pharmaceuticals Inc.总债务$0.05B，净债务($0.01B)。
IMPL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09